Achilles Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Stevenage
Industry:BiotechHealth services
Business model:B2B
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens: protein markers unique to each individual that are present on the surface of a cancer cell and can be detected by the immune system.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 70.13M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Achilles Therapeutics
| Name | Criteria | |
|---|---|---|
![]() |
Aprea Therapeutics
53%
|
|
![]() |
Atai Life Sciences
53%
|
|
![]() |
Biofidelity
53%
|
|
![]() |
BoneSupport
53%
|
|
![]() |
CatalYm
53%
|
|
![]() |
Galecto Biotech
53%
|
|
![]() |
InnovaFeed SAS
53%
|
|
![]() |
LabGenius
53%
|
|
![]() |
MaaT Pharma
53%
|
|
![]() |
MedTrace
53%
|
|





Belgium
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain